PCV74 COST-EFFECTIVENESS OF RIVAROXABAN 2.5MG IN COMBINATION WITH ASPIRIN IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD) OR PERIPHERAL ARTERY DISEASE (PAD) IN GREECE
Abstract
Authors
M. Kalogeropoulou I. Gkouvitsos T. Barlogiannis K. Bowrin J.B. Briere A. Millier A. Karabis